Population
In vitro expressed wild-type and mutant lipoprotein lipases (LPL)
Comparison
Site-directed mutagenesis of putative catalytic… vs Wild-type LPL and mutant LPLs with substitutions…
Design
Preclinical
Authors
Loading...
No clinical implications for LPL deficiencies yet; extends structural insights into the catalytic triad and shielding loop for future research.
In vitro mutagenesis confirms that Asp156-His241-Ser132 constitutes the catalytic triad of lipoprotein lipase and highlights the functional flexibility of its shielding surface loop.
Faustinella et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: